. Overview and Strategy Powering the Immune System to Transform Lives. Vir Biotechnology, Inc. (including its subsidiaries, referred to as Vir Bio, the Company, we, our or us) is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. These diseases represent formidable challenges to human health. Under normal conditions, our immune system is naturally equipped to prote...
Q2 FY2026 — expected 2026-08-20
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-23 | 2025-12-31 | 0001628280-26-010749 | EDGAR | 85K words |
| 2025-02-27 | 2024-12-31 | 0001628280-25-008245 | EDGAR | — |
| 2024-02-26 | 2023-12-31 | 0001628280-24-006852 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0000950170-23-005118 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0000950170-22-002295 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0001564590-21-008915 | EDGAR | — |
| 2020-03-26 | 2019-12-31 | 0001564590-20-013194 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0001628280-25-049694 | EDGAR | 43K words |
| 2025-08-06 | 2025-06-30 | 0001628280-25-038431 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001628280-25-023291 | EDGAR | — |
| 2024-11-04 | 2024-09-30 | 0001628280-24-044995 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0001628280-24-034195 | EDGAR | — |
| 2024-05-03 | 2024-03-31 | 0001628280-24-020299 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0001628280-23-036702 | EDGAR | — |
| 2023-08-04 | 2023-06-30 | 0001628280-23-027527 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0000950170-23-018789 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021854 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0000950170-22-016060 | EDGAR | — |
| 2022-05-05 | 2022-03-31 | 0000950170-22-007811 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-04 | 0001193125-26-091447 | EDGAR | 1K words |
| 2026-03-02 | 0001193125-26-084367 | EDGAR | — |
| 2026-02-26 | 0001193125-26-077416 | EDGAR | — |
| 2026-02-23 | 0001628280-26-010740 | EDGAR | — |
| 2026-01-12 | 0001628280-26-001768 | EDGAR | — |
| 2025-12-16 | 0001628280-25-057394 | EDGAR | — |
| 2025-11-05 | 0001628280-25-049561 | EDGAR | — |
| 2025-08-06 | 0001628280-25-038329 | EDGAR | — |
| 2025-07-24 | 0001628280-25-035847 | EDGAR | — |
| 2025-05-29 | 0001628280-25-028356 | EDGAR | — |
133 total filings indexed. 104 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001706431 |
| Ticker | VIR |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.vir.bio |
| Listed | 2019-10-11 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report